Insys Therapeutics, Inc. 4
4 · Insys Therapeutics, Inc. · Filed May 7, 2015
Insider Transaction Report
Form 4
Babich Michael L
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2015-05-05+60,000→ 60,000 totalExercise: $53.50Exp: 2025-05-04→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 5, 2019.